NSE · Healthcare · Diagnostics & Research
with an average price target of ₹350.00.
| Holder | Stake |
|---|---|
| Orbimed Asia II Mauritius | 12.88% |
| Nippon Life India Trustee Ltd-a/c Nippon India Pha | 7.48% |
| Kotak Small Cap Fund | 6.99% |
| Aditya Birla Sun Life Trustee Private Limited A/C | 3.79% |
| Bandhan Balanced Advantage Fund | 1.09% |
| Document | Date |
|---|---|
| Annual report FY2026 SURAKSHA DIAGNOSTIC LIMITED – FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹31,041.41 lakhs (FY25: ₹25,209.27 lakhs) – growth of 2 | 2026-08-27 |
| Q1 FY27 earnings call SURAKSHA DIAGNOSTIC LIMITED - Q1 FY'27 EARNINGS SUMMARY HEADLINE NUMBERS • Total Income: INR 887 million (Q1 FY'27) vs INR 735 million (Q1 FY'26) — | 2026-08-17 |
| Quarterly results · Q1 FY27 SURAKSHA DIAGNOSTIC LIMITED – Q1 FY27 RESULTS SUMMARY HEADLINE NUMBERS • Total Income: ₹887 million in Q1 FY27, up 21% year-on-year (₹735 million in | 2026-08-12 |
| Investor presentation · Q1 FY27 SURAKSHA DIAGNOSTIC LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from Operations Q1 FY27: INR 876.5 million (up 21% YoY) • EBITDA Q1 FY27: | 2026-08-12 |
| Q4 FY26 earnings call SURAKSHA DIAGNOSTIC LIMITED – Q4 & FY26 SUMMARY --- HEADLINE NUMBERS • FY26 Revenue from Operations: INR 3,104.1 million, up 23.1% YoY (FY25: INR 2 | 2026-05-27 |
| Quarterly results · Q4 FY26 SURAKSHA DIAGNOSTIC LIMITED – FINANCIAL RESULTS SUMMARY FY26 (Year Ended 31 March 2026) --- HEADLINE NUMBERS • Total Income: ₹3,136 million, up 23% | 2026-05-21 |
| Investor presentation · Q4 FY26 SURAKSHA DIAGNOSTIC LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue: ₹3,136 million (+23% YoY) | Q4 FY26: ₹822 million (+25% YoY) • FY26 | 2026-05-21 |
| Q3 FY26 earnings call SURAKSHA DIAGNOSTIC LIMITED - Q3 & 9M FY'26 DOCUMENT SUMMARY --- HEADLINE NUMBERS • Q3 FY'26 Total Income: INR 783.09 million, up 30.3% year-on-yea | 2026-02-12 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹0.50 / share ex-date Sep 15, 2026 | 2026-09-15 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Suraksha Diagnostic Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.